Embecta Corp.

NASDAQ:EMBC

13.3 (USD) • At close May 8, 2025
Bedrijfsnaam Embecta Corp.
Symbool EMBC
Munteenheid USD
Prijs 13.3
Beurswaarde 773,187,972
Dividendpercentage 4.11%
52-weken bereik 10.83 - 21.48
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Devdatt Kurdikar
Website https://www.embecta.com

An error occurred while fetching data.

Over Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its

Vergelijkbare Aandelen

Vaxcyte, Inc. logo

Vaxcyte, Inc.

PCVX

31.45 USD

Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc.

SUPN

31.54 USD

Dynavax Technologies Corporation logo

Dynavax Technologies Corporation

DVAX

9.69 USD

Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc.

XENE

35.54 USD

Travere Therapeutics, Inc. logo

Travere Therapeutics, Inc.

TVTX

20.44 USD

Krystal Biotech, Inc. logo

Krystal Biotech, Inc.

KRYS

137.17 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)